Novartis ‘game changer’ heart shot MIA

By Megan Brodie 3 years ago | In Cell and gene therapies, Companies, Products, Regulatory
  • 3 years ago

17 September 2021 Novartis’ new anti-cholesterol injection LEQVIO (inclisiran) has been registered by the TGA…

This is subscriber-only content. Please login to continue reading.